UTL-10303-60320
2 vaccinations
1 coded response
3 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 21-25
- ZIP prefix
- 276 / NC
- Registered
- 2021-11-14
- Relationship
- Self
- Race
- Multiracial
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-11-08
Dose 1 — Pfizer-BioNTech
-
2021-11-14
Registered in v-safe
- 2021-11-14
-
2021-11-29
Dose 2 — Pfizer-BioNTech
- 2021-11-29
-
2021-12-15
Survey response — day 14, dose 2MedDRA: Chills, Headache, Nasopharyngitis, Pyrexia — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Bad headache, cold symptoms , fever n chillsMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-11-08 | Pfizer-BioNTech | No |
| 2 | 2021-11-29 | Pfizer-BioNTech | No |
Free text
Release 10 — day 14, dose 2
Symptoms: Bad headache, cold symptoms , fever n chills
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Chills | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release